In other countries
The same active substances on other registers, the same brand first.
- Butalbital, Aspirin, Caffeine, and Codeine PhosphateUnited States · 325MG; 50MG; 40MG; 30MG · capsule · Stevens JSame form
- Fiorinal W/CodeineUnited States · 325MG; 50MG; 40MG; 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · capsule · AllerganSame form
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Acetylsalicylic acid, Butalbital, Caffeine, Codeine
- Strength
- 330 MG + 50 MG + 40 MG + 30 MG
- Dosage form
- Capsule
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Not marketed
- Status in the register
- Dormant
- Authorised
- 9 Mar 1998
- Registration
- DIN 01971387
- Marketing authorisation holder
- Laboratoire Riva INC.
- ATC code
- N02AA79
- Group
- Nervous system
- Supply
- NARCOTICS (CDSA I)